Events

Recall of Leica Novocastra Liquid Mouse Monoclonal Antibody NCL-L-CD15

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Leica Biosystems Newcastle Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    16039
  • Event Initiated Date
    2014-10-06
  • Event Country
    New Zealand
  • Event Source
    NZMMDSA
  • Event Source URL
    https://medsafe.govt.nz/hot/Recalls/RecallSearch.asp
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Leica BioSystems Melbourne Pty Ltd, 495 Blackburn Road, Mt Waverley, VIC 3149, AUSTRALIA
  • Reason
    The manufacturer advises the affected lots are not stable up to the expiry date on the product labelling.
  • Action
    Product to be exchanged

Device

Leica Novocastra Liquid Mouse Monoclonal Antibody NCL-L-CD15

Manufacturer

Leica Biosystems Newcastle Ltd